Source:http://linkedlifedata.com/resource/pubmed/id/20878709
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2010-9-29
|
pubmed:abstractText |
Plant extracts such as Hypericum perforatum and Pycnogenol have been tested as alternatives to the classical ADHD drugs. It has been possible to describe neuroprotective effects of such plant extracts. A reduction of ADHD symptoms could be shown in clinical studies after the application of Pycnogenol, which is a pine bark extract. The impacts of the standardized herbal extracts Hypericum perforatum, Pycnogenol and Enzogenol up to a concentration of 5000 ng/mL on cell survival and energy metabolism in human SH-SY5Y neuroblastoma cells has been investigated in the present examination. Hypericum perforatum significantly decreased the survival of cells after treatment with a concentration of 5000 ng/mL, whereas lower concentrations exerted no significant effects. Pycnogenol( induced a significant increase of cell survival after incubation with a concentration of 32.25?ng/mL and a concentration of 250 ng/mL. Other applied concentrations of Pycnogenol failed to exert significant effects. Treatment with Enzogenol did not lead to significant changes in cell survival.Concerning energy metabolism, the treatment of cells with a concentration of 5000 ng/mL Hypericum perforatum led to a significant increase of ATP levels, whereas treatment with a concentration of 500 ng/mL had no significant effect. Incubation of cells with Pycnogenol and Enzogenol exerted no significant effects.None of the tested substances caused any cytotoxic effect when used in therapeutically relevant concentrations.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Flavonoids,
http://linkedlifedata.com/resource/pubmed/chemical/Plant Extracts,
http://linkedlifedata.com/resource/pubmed/chemical/Quercetin,
http://linkedlifedata.com/resource/pubmed/chemical/enzogenol,
http://linkedlifedata.com/resource/pubmed/chemical/pycnogenols
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1099-1573
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2010 John Wiley & Sons, Ltd.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1549-53
|
pubmed:meshHeading |
pubmed-meshheading:20878709-Attention Deficit Disorder with Hyperactivity,
pubmed-meshheading:20878709-Cell Line, Tumor,
pubmed-meshheading:20878709-Cell Survival,
pubmed-meshheading:20878709-Energy Metabolism,
pubmed-meshheading:20878709-Flavonoids,
pubmed-meshheading:20878709-Humans,
pubmed-meshheading:20878709-Hypericum,
pubmed-meshheading:20878709-Phytotherapy,
pubmed-meshheading:20878709-Plant Extracts,
pubmed-meshheading:20878709-Quercetin
|
pubmed:year |
2010
|
pubmed:articleTitle |
Impact of plant extracts tested in attention-deficit/hyperactivity disorder treatment on cell survival and energy metabolism in human neuroblastoma SH-SY5Y cells.
|
pubmed:affiliation |
Department of Psychiatry and Psychotherapy, Philipps-University, Marburg, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|